Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET
Abstract
:1. Introduction
2. Materials and Methods
2.1. Cell Culture
2.2. Tubeimoside-1 Treatment
2.3. Cell Viability Assay
2.4. BrdU Staining
2.5. Flow Cytometry Analysis
2.6. Western Blot Analysis
2.7. Transfection and Infection
2.8. qRT-PCR Assay
2.9. Soft Agar Assay
2.10. Tumor Xenografts
2.11. Orthotopic Implantation Assay
2.12. Ubiquitination Assay
2.13. Statistics Analysis
3. Results
3.1. TBMS1 Inhibits Glioblastoma Cell Proliferation
3.2. TBMS1 Causes Glioblastoma Cells Cell Cycle Arrest at G2/M Phase
3.3. TBMS1 Blocks Glioblastoma Cells Migration and Invasion
3.4. TBMS1 Inhibits Glioblastoma Cells Activation of AKT, ERK Pathway by Enhancing MET Ubiquitination Degradation
3.5. TBMS1 Inhibits Glioblastoma Cells Clonogenicity, Tumorigenesis, and the Expression of MET
4. Discussion and Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Gurney, J.G.; Kadan-Lottick, N. Brain and other central nervous system tumors: Rates, trends, and epidemiology. Curr. Opin. Oncol. 2001, 13, 160–166. [Google Scholar] [CrossRef] [PubMed]
- Stupp, R.; Hegi, M.E.; Van Den Bent, M.J.; Mason, W.P.; Weller, M.; Mirimanoff, R.O.; Cairncross, J.G. Changing paradigms—An update on the multidisciplinary management of malignant glioma. Oncologist 2006, 11, 165–180. [Google Scholar] [CrossRef] [PubMed]
- Goodwin, C.R.; Lal, B. Crizotinib and erlotinib inhibits growth of c-Met+/EGFRvIII+ primary human glioblastoma xenografts. Clin. Neurol. Neurosurg. 2018, 171, 26–33. [Google Scholar] [CrossRef] [PubMed]
- Cruickshanks, N.; Zhang, Y.; Hine, S.; Gibert, M.; Yuan, F.; Oxford, M.; Grello, C.; Pahuski, M.; Dube, C.; Abounader, R.; et al. Discovery and therapeutic exploitation of mechanisms of resistance to MET inhibitors in glioblastoma. Clin. Cancer Res. 2019, 25, 663–673. [Google Scholar] [CrossRef] [PubMed]
- Jia, G.; Wang, Q.; Wang, R.; Deng, D.; Xue, L.; Shao, N.; Zhang, Y.; Xia, X.; Zhi, F.; Yang, Y. Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway. OncoTargets Ther. 2015, 8, 303–311. [Google Scholar] [Green Version]
- Gu, Y.; Korbel, C.; Scheuer, C.; Nenicu, A.; Menger, M.D.; Laschke, M.W. Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model. Oncotarget 2016, 7, 5258–5572. [Google Scholar] [CrossRef] [PubMed]
- Peng, Y.; Zhong, Y.; Li, G. Tubeimoside-1 suppresses breast cancer metastasis through downregulation of CXCR4 chemokine receptor expression. BMB Rep. 2016, 49, 502–507. [Google Scholar] [CrossRef] [PubMed]
- Bian, Q.; Liu, P.; Gu, J.; Song, B. Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/b-catenin signaling pathway. Int. J. Clin. Exp. Pathol. 2015, 8, 12517–12524. [Google Scholar]
- Yang, J.B.; Khan, M.; He, Y.Y.; Yao, M.; Li, Y.M.; Gao, H.W.; Ma, T.H. Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0/G1 phase arrest in human prostate carcinoma cells in vitro. Acta Pharm. Sin. 2016, 37, 950–962. [Google Scholar] [CrossRef] [Green Version]
- Cui, Z.; Shi, X.; Liu, X.; Su, Z.; Xu, H.; Ju, X.; Li, G.; Zhao, H. Determination of tubeimoside I content in Bolbostemma paniculatum (Maxim.) Franquet and its anti-proliferative effect on human erythroleukemia K562 cells. Biomed. Res. 2016, 27, 1171–1173. [Google Scholar]
- Fulda, S. Targeting apoptosis for anticancer therapy. Semin. Canc. Biol. 2015, 31, 84–88. [Google Scholar] [CrossRef] [PubMed]
- Hassan, M.; Watari, H.; AbuAlmaaty, A.; Ohba, Y.; Sakuragi, N. Apoptosis and molecular targeting therapy in cancer. Biomed. Res. Int. 2014, 2014, 150845. [Google Scholar] [CrossRef]
- Jiang, S.L.; Guan, Y.D.; Chen, X.S.; Ge, P.; Wang, X.L.; Lao, Y.Z.; Xiao, S.S.; Zhang, Y.; Yang, J.M.; Xu, X.J.; et al. Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway. Acta Pharmacol. Sin. 2018, 12, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Ma, R.D.; Yu, L.J.; Su, W.M.; Shao, H.Y.; Liao, M.N.; He, D.M.; Huang, L.Z. Induction of cell cycle arrest and apoptosis by tubeimoside I isolated from Bolbostemma Paniculatum in HeLa cells. Chin. J. Clin. Pharm. Ther. 2004, 9, 261–269. [Google Scholar]
- Yang, P.; Yu, T.X.; Ma, R.D.; Yu, L.J.; Su, W.M.; Shao, H.Y.; Liao, M.N.; Huang, L.Z. Cell cycle arrest and apoptosis induced by tubeimoside in HeLa cell. Ai Zheng 2002, 21, 346–350. [Google Scholar]
- Wu, T.; Cui, H.; Xu, Y.; Du, Q.; Zhao, E.; Cao, J.; Nie, L.; Fu, G.; Ren, A. The effect of tubeimoside-1 on the proliferation, metastasis and apoptosis of oral squamous cell carcinoma in vitro. OncoTargets Ther. 2018, 11, 3989–4000. [Google Scholar] [CrossRef] [PubMed]
- Liu, J.Y.; Gao, Y.; Yu, L.J. Differentiation-inducing activity of tubeimoside I in human erythroleukemia K562 cells. Chin. J. Clin. Pharm. Ther. 2006, 11, 43–58. [Google Scholar]
- Hu, D.H.; Ma, R.D.; Yu, L.J. Inhibition of angiogenesis by tubeimoside I isolated from Bolstemma paniculatun. Chin. Pharm. Bull. 2003, 19, 715–716. [Google Scholar]
- Wu, Q.; Sun, G.; Yuan, X.; Soromou, L.W.; Chen, N.; Xiong, Y.; Feng, H. Tubeimoside-1 attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models. Immunopharmacol. Immunotoxicol. 2013, 35, 514–523. [Google Scholar] [CrossRef]
- Sonnenberg, E.; Meyer, D.; Weidner, K.M.; Birchmeier, C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 1993, 123, 223–235. [Google Scholar] [CrossRef]
- Appleman, L.J. MET signaling pathway: A rational target for cancer therapy. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2011, 29, 4837–4838. [Google Scholar] [CrossRef] [PubMed]
- State Administration of Traditional Chinese Medicine, Editorial Board of China Herbal; Shanghai Scientific and Technical Publishers: Shanghai, China, 1999; Volume 5, p. 502.
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cao, J.; Zhao, E.; Zhu, Q.; Ji, J.; Wei, Z.; Xu, B.; Cui, H. Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET. Cells 2019, 8, 774. https://doi.org/10.3390/cells8080774
Cao J, Zhao E, Zhu Q, Ji J, Wei Z, Xu B, Cui H. Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET. Cells. 2019; 8(8):774. https://doi.org/10.3390/cells8080774
Chicago/Turabian StyleCao, Jiangjun, Erhu Zhao, Qingzong Zhu, Juanli Ji, Zekun Wei, Bo Xu, and Hongjuan Cui. 2019. "Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET" Cells 8, no. 8: 774. https://doi.org/10.3390/cells8080774